SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: EmuGreg who wrote (638)4/8/1998 11:15:00 PM
From: DELT1970  Respond to of 4140
 
EG: Anecdotal evidence will also play a large part in the model. This weekend everytime the camera at the Masters Tournament focuses on Tom Kite, the commentator will say something to the effect: he has fabulous vision since his procedure and the glasses are but a memory. Baby boomers will lap it up, as they will similarly when they hear the same story about racecar driver, Bobby Rahal. At this point in demand creation, it's not important whose procedure it is; it's that it's a successful outcome.



To: EmuGreg who wrote (638)4/9/1998 1:58:00 AM
From: HeyRainier  Read Replies (2) | Respond to of 4140
 
Okay, we start with an estimated 100 million people in the US and Europe that have hyperopia (taken from the SNRS web site).

That's a step.

Now, what percentage will actualy take the procedure?

And what is the cost per procedure?

Rainier


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News